Feature | Nuclear Imaging | November 05, 2019 | Dave Fornell, Editor

Philips Forte Gamma Camera Recalled for Possibility of Crushing Patient

Older SPECT camera is under a Class I recall

Philips Medical System is recalling its older Forte Gamma Camera SPECT imaging systems due to the possibility of the detectors falling off of the unit onto the patient. The two gamma cameras can bee seen in this photo on either side of the patient bed. These can be rotated above the patient.

Philips Medical System is recalling its older Forte Gamma Camera SPECT imaging systems due to the possibility of the detectors falling off of the unit onto the patient. The two gamma cameras can be seen in this photo on either side of the patient bed. These can be rotated above the patient.

November 5, 2019 — Philips Medical System is recalling the Forte Gamma Camera System due to the potential for the 660-pound detector to detach from the device without warning. The vendor said this could result in a serious injury, such as crushing, trapping or killing the patient. The U.S. Food and Drug Administration (FDA) reported Philips received one customer complaint, but no serious injuries or deaths were reported.

The FDA said this is a Class I recall, due to potential for the nuclear imaging detector to become detached, which can result in injury or death. Philips told its customers to discontinue use of the Forte Gamma Camera System until further notice. Philips initiated its recall Sept. 19, 2019. It includes 852 devices recalled in the United States.

The FDA and Philips are taking precautions because of a June 2013 accident, when the detector on a GE Healthcare SPECT system fell onto a patient and killed them during a scan at the James J. Peters VA Medical Center in the Bronx, N.Y. That incident resulted in a similar recall at the time for GE's nuclear imaging systems. Read the article Patient Killed During Nuclear Imaging Scan.

The Forte Gamma Camera System is an older single photon emission computed tomography (SPECT) nuclear imaging system. These systems were manufactured between Jan. 1, 1998 and Dec. 31, 2008. It is used to create images of structures or functions inside the body of patients using a radioisotope tracer to diagnose, plan treatment and evaluate many conditions, including cancer and cardiac perfusion.

The recalled products include the following imaging system:
   • Philips Medical System Forte Gamma Camera System
   • Forte (882020)
   • Forte Jetstream (882290)
   • Forte Jetstream upgrade (882291)
   • Forte Jetstream AZ (882320)
   • Forte Jetstream AZ upgrade (882321)
   • Diamond Select Forte (889456)
   • Diamond Select Forte JETStream (889471)

A portion of the gamma camera head weight comes from the heavy lead collimators built into them. 

Philips sent a letter to customers who purchased the affected systems and provided the following instructions:
   • Discontinue use of the Forte Gamma Camera System until further notice
   • Maintain the letter with the Forte Gamma Camera System until a correction is made to the system
   • Complete the Customer Response Form and e-mail it to [email protected]

Healthcare providers and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program. Complete and submit the report online. Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the form, or submit by fax to 1-800-FDA-0178.

Access original FDA recall notice
 

Related Content

Image by Dr. Manuel González Reyes from Pixabay

Image by Dr. Manuel González Reyes from Pixabay 

News | SPECT Imaging | November 08, 2019
November 8, 2019 — Using ground-breaking technology, researchers at the...
 Phoenix’s fusion neutron generation technology.
News | Radiopharmaceuticals and Tracers | October 28, 2019
October 28, 2019 — Phoenix LLC and Shine Medical Technologies LLC, nuclear technology companies focused on near-term
GE Healthcare and Theragnostics Partnering on PSMA PET/CT Imaging Agent
News | Prostate Cancer | October 16, 2019
GE Healthcare and Theragnostics have entered into a global commercial partnership for a new prostate-specific membrane...
ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along
A 3-D printed tungsten pre-clinical X-ray system collimator. 3D printed, additive manufacturing for medical imaging.

A 3-D printed tungsten pre-clinical X-ray system collimator. The tungsten alloy powder is printed into the form desired and is laser fused so it can be machined and finished. Previously, making collimators from Tungsten was labor intensive because it required working with sheets of the metal to create the collimator matrix. 

Feature | Medical 3-D Printing | September 04, 2019 | By Steve Jeffery
In ...
A SPECT nuclear scan of the heart to show perfusion defects in the myocardium due to coronary artery blockages or heart attack. The imaging uses the Mo-99 based medical imaging isotope Tc-99m. The U.S. government has created policy to move away from use of highly enriched uranium (HEU) to low-enriched uranium (LEU) for Mo-99 isotope production, but there is one hold out who has not yet converted before a 2020 deadline. Photo courtesy of Philips Healthcare.

A SPECT nuclear scan of the heart to show perfusion defects in the myocardium due to coronary artery blockages or heart attack. The imaging uses the Mo-99 based medical imaging isotope Tc-99m. The U.S. government has created policy to move away from use of highly enriched uranium (HEU) to low-enriched uranium (LEU) for Mo-99 isotope production, but there is one holdout who has not yet converted before a 2020 deadline. Photo courtesy of Philips Healthcare.

Feature | Nuclear Imaging | August 30, 2019 | Dave Fornell, Editor
In a surprising move, the National Institute for Radioelements (IRE) has applied for a new license to export highly e
University of Alabama at Birmingham Leading Production of Theranostic Radioisotope

Image courtesy of the University of Alabama at Birmingham

News | Radiopharmaceuticals and Tracers | August 29, 2019
The University of Alabama at Birmingham, in conjunction with researchers at the University of Wisconsin and Argonne...
United Imaging Announces First U.S. Clinical Installation of uExplorer Total-body PET/CT
News | PET-CT | August 15, 2019
United Imaging announced that its uExplorer total-body positron emission tomography/computed tomography (PET/CT) system...
ASRT Supports Radiopharmaceutical Reimbursement Bill
News | Radiopharmaceuticals and Tracers | August 02, 2019
The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) 3772, a measure...